BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

389 related articles for article (PubMed ID: 29782900)

  • 1. Basal cell carcinoma: Epidemiology; pathophysiology; clinical and histological subtypes; and disease associations.
    Cameron MC; Lee E; Hibler BP; Barker CA; Mori S; Cordova M; Nehal KS; Rossi AM
    J Am Acad Dermatol; 2019 Feb; 80(2):303-317. PubMed ID: 29782900
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Personal history of psoriasis and risk of nonmelanoma skin cancer (NMSC) among women in the United States: A population-based cohort study.
    Dai H; Li WQ; Qureshi AA; Han J
    J Am Acad Dermatol; 2016 Oct; 75(4):731-735. PubMed ID: 27436157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Model to Predict the Risk of Keratinocyte Carcinomas.
    Whiteman DC; Thompson BS; Thrift AP; Hughes MC; Muranushi C; Neale RE; Green AC; Olsen CM;
    J Invest Dermatol; 2016 Jun; 136(6):1247-1254. PubMed ID: 26908057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Keratinocyte Carcinoma as a Marker of a High Cancer-Risk Phenotype.
    Small J; Barton V; Peterson B; Alberg AJ
    Adv Cancer Res; 2016; 130():257-91. PubMed ID: 27037755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors for squamous cell carcinoma of the skin with two illustrative cases and literature review.
    Owczarek W; Majewski S; Schwartz RA
    Acta Dermatovenerol Croat; 2011; 19(1):21-7. PubMed ID: 21489362
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Basal cell carcinoma: Contemporary approaches to diagnosis, treatment, and prevention.
    Cameron MC; Lee E; Hibler BP; Giordano CN; Barker CA; Mori S; Cordova M; Nehal KS; Rossi AM
    J Am Acad Dermatol; 2019 Feb; 80(2):321-339. PubMed ID: 29782901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frequency of facial basal cell carcinoma does not correlate with site-specific UV exposure.
    Heckmann M; Zogelmeier F; Konz B
    Arch Dermatol; 2002 Nov; 138(11):1494-7. PubMed ID: 12437456
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroendocrine factors: The missing link in non‑melanoma skin cancer (Review).
    Lupu M; Caruntu A; Caruntu C; Papagheorghe LML; Ilie MA; Voiculescu V; Boda D; Constantin C; Tanase C; Sifaki M; Drakoulis N; Mamoulakis C; Tzanakakis G; Neagu M; Spandidos DA; Izotov BN; Tsatsakis AM
    Oncol Rep; 2017 Sep; 38(3):1327-1340. PubMed ID: 28713981
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemiology of skin cancer.
    Leiter U; Eigentler T; Garbe C
    Adv Exp Med Biol; 2014; 810():120-40. PubMed ID: 25207363
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histopathological study of perilesional skin in patients diagnosed with nonmelanoma skin cancer.
    Apalla Z; Calzavara-Pinton P; Lallas A; Argenziano G; Kyrgidis A; Crotti S; Facchetti F; Monari P; Gualdi G
    Clin Exp Dermatol; 2016 Jan; 41(1):21-5. PubMed ID: 26189480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. UV dose determines key characteristics of nonmelanoma skin cancer.
    Ramos J; Villa J; Ruiz A; Armstrong R; Matta J
    Cancer Epidemiol Biomarkers Prev; 2004 Dec; 13(12):2006-11. PubMed ID: 15598755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence of basal cell and squamous cell carcinomas in a population younger than 40 years.
    Christenson LJ; Borrowman TA; Vachon CM; Tollefson MM; Otley CC; Weaver AL; Roenigk RK
    JAMA; 2005 Aug; 294(6):681-90. PubMed ID: 16091570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cutaneous keratinocyte cancers of the head and neck: Epidemiology, risk factors and clinical, dermoscopic and reflectance confocal microscopic features.
    Lee KJ; Soyer HP
    Oral Oncol; 2019 Nov; 98():109-117. PubMed ID: 31585338
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ultraviolet carcinogenesis in nonmelanoma skin cancer part II: review and update on epidemiologic correlations.
    Almahroos M; Kurban AK
    Skinmed; 2004; 3(3):132-9. PubMed ID: 15133392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence Estimate of Nonmelanoma Skin Cancer (Keratinocyte Carcinomas) in the U.S. Population, 2012.
    Rogers HW; Weinstock MA; Feldman SR; Coldiron BM
    JAMA Dermatol; 2015 Oct; 151(10):1081-6. PubMed ID: 25928283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nonmelanoma skin cancer and risk of all-cause and cancer-related mortality: a systematic review.
    Barton V; Armeson K; Hampras S; Ferris LK; Visvanathan K; Rollison D; Alberg AJ
    Arch Dermatol Res; 2017 May; 309(4):243-251. PubMed ID: 28285366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence trends of nonmelanoma skin cancer in Germany from 1998 to 2010.
    Rudolph C; Schnoor M; Eisemann N; Katalinic A
    J Dtsch Dermatol Ges; 2015 Aug; 13(8):788-97. PubMed ID: 26213814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk Factors for Keratinocyte Carcinoma in Recipients of Allogeneic Hematopoietic Cell Transplants.
    Scott JF; Brough KR; Grigoryan KV; Muzic JG; Kim GY; Conic RRZ; Hill ST; Brewer JD; Baum CL; Litzow MR; Hogan WJ; Patnaik MS; Hashmi SK; Lazarus HM; Bordeaux JS; Thompson CL; Gerstenblith MR; Lehman JS
    JAMA Dermatol; 2020 Jun; 156(6):631-639. PubMed ID: 32267479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cigarette Smoking and the Risks of Basal Cell Carcinoma and Squamous Cell Carcinoma.
    Dusingize JC; Olsen CM; Pandeya NP; Subramaniam P; Thompson BS; Neale RE; Green AC; Whiteman DC;
    J Invest Dermatol; 2017 Aug; 137(8):1700-1708. PubMed ID: 28414022
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Skin cancer in solid organ transplant recipients: advances in therapy and management: part I. Epidemiology of skin cancer in solid organ transplant recipients.
    O'Reilly Zwald F; Brown M
    J Am Acad Dermatol; 2011 Aug; 65(2):253-261. PubMed ID: 21763561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.